Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications drug utilization physician survey intron a® europe
… Cross-Sectional Survey of Pneumococcal Vaccine Prescribers OPPORTUNITY The … for changes to the CDC’s ACIP recommendations ahead of a recent update, our client was interested in gaining a … ≥ 65 years. OUR APPROACH We conducted a cross-sectional survey among US HCPs who prescribe and administer …
… Preferences Benefit-risk preference studies are a specific application of stated-preference methods and are … caregivers, and physicians will make when provided with a set of actual treatment options. Benefit-risk preference … the relative importance of benefits and risks and a patient’s maximum acceptable risk (MAR). If the actual risk …
… Wednesday, February 7, 2024 Meeting website In response to a US Congressional request, an ad hoc committee of the … Sciences, Engineering, and Medicine (NASEM) will conduct a study in the United States and the European Union on the … meeting of the committee; the meeting will be conducted in a virtual environment. There will be an opportunity for …
… Drug Safety in Pregnancy Satisfy Regulatory Requirements With … to treat conditions related to pregnancy. If you have a new drug, biologic, vaccine, or medical device entering the …
… successful reimbursement and patient access. Creating a strategic plan with a Market Access Evidence Roadmap can help you identify areas … You’ll learn about strategic planning necessary for orphan drug development as we cover: Market Access Evidence Roadmaps …
… data sources Decision-analytic models Disease prevalence Drug utilization studies Economic analyses of clinical trial … Reimbursement and value communication strategies Survey development, evaluation and implementation …
… regulatory submissions, epidemiology studies, and drug, vaccine, and medical technology safety and … Negotiating post-approval study commitments Determining if a post-marketing observational study could address a safety … such as those to address issues of nonrandom assignment of drug treatment Providing training on epidemiology methods, …
… Epidemiologist at RTI-HS, will be participating as a panelist at the 13th Annual Sentinel Initiative Public … by the Duke-Margolis Center for Health Policy under a cooperative agreement with the FDA. Dr. Layton will be … safety protocols. The annual public workshop will be a virtual gathering of the Sentinel community and leading …
… of Risk Minimization Measures on the Use of Cilostazol in Europe J Castellsague, B Calingaert , B Poblador-Plou, M Giner-Soriano, M Linder, O Scholle, A Arana Navarro, C Bui , C Laguna, A Prados-Torres, A Roso-Llorach, S Perez-Gutthann …
… understanding the underlying real-world data. We performed a large evaluation of the comparative safety of high-dose and … We wanted to understand how the unique healthcare utilization patterns of patients with ESRD could affect our … occur with predictable frequency like dialysis sessions or physician visits. In medically complex populations with …